Home
Conditions
Lymphoma, Mantle-Cell

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

889 public trials 111 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Recruiting

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

NCT06340737

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +38 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Recruiting

A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer

NCT05659732

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: Monash Medical Centre Clayton, Victoria, Australia

Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan

China Medical University Hospital Taichung, Taiwan

Chang Gung Memorial Hospital- Linkou Taipei, Taiwan

View Trial Details

Recruiting

A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies

NCT06045910

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: University Hospital Birmingham NHS Foundation Trust Birmingham, United Kingdom

Cambridge University Hospitals Cambridge, United Kingdom

St James's University Hospital Leeds, United Kingdom

University Hospital London Hospital London, United Kingdom

View Trial Details

Recruiting

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

NCT00935090

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Recruiting

Acalabrutinib Plus Rituximab for the Treatment of Elderly or Low- to Intermediate-Risk Younger Untreated Mantle Cell Lymphoma

NCT06846489

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Sun yat-sen university cancer center, Sun yat-sen university Guangzhou, Guangdong, China

View Trial Details

Recruiting

Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma

NCT05635162

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Royal Derby Hospital Derby, United Kingdom

Beatson West of Scotland Cancer Centre Glasgow, United Kingdom

Clatterbridge Cancer Centre Liverpool, United Kingdom

Guy's Hospital London, United Kingdom

View all 13 locations

View Trial Details

Recruiting

A Study of Patients With Relapsed/Refractory Mantle Cell Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting

NCT06788652

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Center for International Blood and Marrow Transplant Research (CIBMTR) Milwaukee, Wisconsin, United States

View Trial Details

Recruiting

Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma

NCT06464861

Conditions: Diffuse Large B Cell Lymphoma( DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: the Second Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Phase Ib Clinical Study of Keynatinib

NCT04807881

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Peking University Third Hospital Beijing, Beijing Municipality, China

Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

West China Hospital，Sichuan University Chengdu, Sichuan, China

View Trial Details

Recruiting

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

NCT05281809

Conditions: B Acute Lymphoblastic Leukemia, B-cell Lymphoma, Burkitt Lymphoma, +36 more
Locations: AHN Cancer Institute - West Penn Hospital Pittsburgh, Pennsylvania, United States

View Trial Details

Lymphoma, Mantle-Cell

Lymphoma, Mantle-Cell trial results

Related conditions